Filter
1640
Text search:
registration
of
drugs
Featured
Recommendations
140
New Publications
538
Language
Document type
No document type
1105
Guidelines
186
Studies & Reports
175
Manuals
69
Strategic & Response Plan
63
Training Material
16
Situation Updates
10
Fact sheets
10
Resource Platforms
5
Brochures
1
Countries / Regions
India
160
Kenya
72
Sierra Leone
46
Nigeria
45
Uganda
45
Nepal
41
Ghana
40
Ethiopia
39
South Africa
38
Rwanda
37
Tanzania
35
Malawi
34
Global
33
Liberia
31
Bangladesh
31
Western and Central Europe
31
Myanmar / Burma
27
Africa
26
Zambia
24
Namibia
24
Ukraine
22
Botswana
19
Eastern Europe
17
Latin America and the Carribbean
16
Zimbabwe
15
Syria
15
Philippines
14
Cambodia
13
Indonesia
13
Lesotho
13
South Sudan
12
Asia
12
Mozambique
10
Congo, Democratic Republic of
9
South–East Asia Region
9
Pakistan
6
Eswatini/ Swaziland
6
Senegal
5
Tajikistan
5
Russia
5
Jordan
4
Lebanon
4
Sudan
4
Benin
4
East and Southern Africa
4
Eastern Europe and Central Asia
4
Albania
4
Cameroon
3
Haiti
3
Iraq
3
Afghanistan
3
Germany
3
North Macedonia
3
Colombia
3
Sri Lanka
3
West and Central Africa
3
Moldova
3
Iran
3
Georgia
3
Burkina Faso
2
Saudi Arabia
2
China
2
Argentina
2
Greece
2
Libya
2
Chile
2
Bhutan
2
Venezuela
2
Palestine
2
Armenia
2
Laos
2
Timor Leste/ East Timor
2
Turkmenistan
2
Côte d’Ivoire / Ivory Coast
1
Morocco
1
USA
1
Somalia
1
Egypt
1
Thailand
1
Gambia
1
Malaysia
1
Ireland
1
Singapore
1
Papua New Guinea
1
Central African Republic
1
Peru
1
Brazil
1
Ecuador
1
Bolivia
1
Angola
1
Madagascar
1
Yemen
1
Middle East and North Africa
1
Paraguay
1
Fiji
1
Djibouti
1
Qatar
1
Bulgaria
1
Lithuania
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
Vietnam
1
North America
1
Denmark
1
Maldives
1
Tunisia
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
854
Clinical Guidelines
123
Public Health
64
Women & Child Health
59
Key Resources
51
Pharmacy & Technologies
28
Capacity Building
22
Toolboxes
TB
167
HIV
157
Pharmacy
70
Mental Health
67
AMR
66
COVID-19
44
Conflict
41
NTDs
38
Caregiver
33
Refugee
25
Disability
22
NCDs
22
Malaria
21
Global Health Education
14
Rapid Response
13
Ebola & Marburg
10
Natural Hazards
10
Planetary Health
9
Specific Hazards
8
Health Financing Toolbox
6
Polio
4
Zika
3
2.0 Rapid Response
3
South Sudan
2
Social Ethics
2
Cholera
1
La publication fournit une vue d'ensemble et une analyse des instruments internationaux qui établissent des normes relatives à l'utilisation des antimicrobiens dans les secteurs humain, animal et végétal, et à leur rejet dans l'environnement. L'objectif de ce document est d'identifier les instr
...
This Pharmaceutical Country Profile for Kenya (2010) has been developed by the Ministry of Medical Services with support of the World Health Organization. The Profile contains information on existin
...
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to
...
Situational Analysis: 13-23 October 2014
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Manual for use in primary care.
There is substantial evidence for the benefits of screening and brief intervention in primary health care for alcohol problems. However, there is a need for screening and brief interventions with cross-cultural rele
...
The training focuses on building the capacity of health care workers at the primary and secondary level to address and manage TB in children.
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in
...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability
...
Framework for implementation.
The END TB Strategy.
Document No. : FDA/SMC/SMD/GL-SMP/2015/05 |
These guidelines are for information, guidance and strict compliance by Marketing Authorization Holders and Local Representatives of regulated products to help in the continuous safety monitoring
...
6th edition